Health
FDA finds control failures at Moderna manufacturing plant
US drug regulators found quality control gaps at Moderna’s main manufacturing plant, including with equipment used to make the drug substance for its COVID-19 vaccine,
US FDA approves Arcutis’ drug for the treatment of chronic skin conditions
The US Food and Drug Administration has approved Arcutis Biotherapeutics’ drug to treat a skin condition called seborrheic dermatitis in people aged nine and older.
Bristol Myers to stop research into colorectal cancer treatment
Bristol Myers Squibb has said it will discontinue the last phase of a trial testing a treatment for a type of colorectal cancer. The company
US FDA approves Astellas combination therapy for bladder cancer
The US Food and Drug Administration has approved Astellas Pharma’s Padzeva in combination with Merck’s Keytruda for a type of bladder cancer. In April, the
The US FDA has approved the Medtronic system for the treatment of heart disease
Medtronic announced that the U.S. Food and Drug Administration has approved its system to treat conditions that can cause stroke or heart failure. The PulseSelect
US healthcare spending to rise to $4.5 trillion in 2022
US healthcare spending rose 4.1 per cent in 2022 to $4.5 trillion, federal data showed. Officials said the figure indicates a return to pre-pandemic patterns
Pfizer shares fall after revising COVID expectations for 2024
Pfizer predicts sales in 2024 could be $5bn below Wall Street expectations, sending shares to a 10-year low. Revenue from Pfizer’s COVID-19 vaccine and treatment,
Eisai to launch Alzheimer’s disease drug Leqembi in Japan 20 Dec
Eisai said its Alzheimer’s disease drug Leqembi will go on sale in Japan on 20 December after being included in the national health insurance price
US Commission recommends obese children start counselling from age 6
Obese children should receive intensive counselling to promote healthy eating and exercise starting at age 6, according to a draft recommendation published by a panel
Pfizer gets approval for $43 billion deal with Seagen after donating rights to cancer drugs
Pfizer said it expects to close a $43 billion deal to buy cancer drug maker Seagen later this week and plans to create a new